Clinical trials have demonstrated that both biosimilars match the reference product's quality, safety and efficacy standards.

CA Rudramurthy BV is bullish on Biocon and DMart, citing strong technical setups and sectoral promise. Biocon’s breakout from ...

Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

Bengaluru: A war of words has erupted between Biocon founder Kiran Mazumdar-Shaw and Karnataka Chief Minister Siddaramaiah on ...

The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...

Biocon founder Kiran Mazumdar Shaw and Karnataka Chief Minister Siddaramaiah debated on X over the safety of Covid-19 ...

Biocon Biologics gets EU approval for Denosumab biosimilars Vevzuo & Evfraxy, expanding access to bone disease treatments across Europe.

The Karnataka CM has suggested that the recent heart attack deaths in Hassan district may be linked to the vaccination drive ...

Biocon chief Kiran Mazumdar-Shaw has pushed back against Karnataka Chief Minister Siddaramaiah's recent claim that COVID-19 ...

Yesafili is a VEGF inhibitor indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD), ...

Biocon founder Kiran Mazumdar-Shaw refutes Karnataka CM's claim linking Covid-19 vaccines to heart attack deaths in Hassan ...